614MO Cabazitaxel (CBZ) activity in men with metastatic castration resistant prostate cancer (mCRPC) with and without DNA damage repair (DDR) defects von Aldea, M., Lam, L., Llacer Perez, C., Saint-Ghislain, M., Mescam, G. Gravis, Fléchon, A., Roubaud, G., Barthélémy, P., Ricci, F., Priou, F., Neviere, Z.M., Beaufils, M., Helissey, C., Ratta, R., Pobel, C., Marcos, E. Castro, Thiery-Vuillemin, A., Baciarello, G., Orillard, E., Fizazi, K.

Volltext